Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published

Updated on: January 02,2024

Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published

Updated on:January 02,2024

Use of MMR deficiency testing in younger CRC patients is low

(HealthDay)—Fewer than half of younger adults with colorectal cancer (CRC) undergo mismatch repair (MMR) deficiency of DNA testing, according to a study published online Nov. 9 inJAMA Oncology.T

Updated on: April 22,2024

Use of MMR deficiency testing in younger CRC patients is low

(HealthDay)—Fewer than half of younger adults with colorectal cancer (CRC) undergo mismatch repair (MMR) deficiency of DNA testing, according to a study published online Nov. 9 inJAMA Oncology.T

Updated on:April 22,2024

Improving health outcomes with a little help from our friends—and artificial intelligence

by Medical University of South CarolinaDr. Chanita Hughes-Halbert of the Medical University of South Carolina and Hollings Cancer Center studies social determinants of health and health dispariti

Updated on: April 22,2024

Improving health outcomes with a little help from our friends—and artificial intelligence

by Medical University of South CarolinaDr. Chanita Hughes-Halbert of the Medical University of South Carolina and Hollings Cancer Center studies social determinants of health and health dispariti

Updated on:April 22,2024

New study shows Medicaid expansion associated with increase in palliative care for patients with advanced cancers

byAmerican Cancer SocietyMore people with advanced cancers in the United States received critical palliative care services, according to new findings by researchers at the American Cancer Societ

Updated on: January 12,2024

New study shows Medicaid expansion associated with increase in palliative care for patients with advanced cancers

byAmerican Cancer SocietyMore people with advanced cancers in the United States received critical palliative care services, according to new findings by researchers at the American Cancer Societ

Updated on:January 12,2024

Taming overactive molecular signaling in renal cell cancer

by Johns Hopkins University School of MedicineMurine renal tumors with Tsc2 loss have increased TFEB/TFE3 nuclear localization. Credit: Clarence Rachel Villanueva and Adrianna A. Mendes,Nat

Updated on: February 01,2024

Taming overactive molecular signaling in renal cell cancer

by Johns Hopkins University School of MedicineMurine renal tumors with Tsc2 loss have increased TFEB/TFE3 nuclear localization. Credit: Clarence Rachel Villanueva and Adrianna A. Mendes,Nat

Updated on:February 01,2024

Financial toxicity of cancer impacts partners' quality of life, says study

by Nicole Fawcett,University of MichiganAssociations Between Health-Related Quality of Life Domains and Financial Toxicity Outcomes. Credit:JAMA Network Open(2023). DOI: 10.1001/jama

Updated on: January 16,2024

Financial toxicity of cancer impacts partners' quality of life, says study

by Nicole Fawcett,University of MichiganAssociations Between Health-Related Quality of Life Domains and Financial Toxicity Outcomes. Credit:JAMA Network Open(2023). DOI: 10.1001/jama

Updated on:January 16,2024

Using donor CAR T cells shows promise in treating myeloma patients in phase I trial

by Bob Yirka , Medical XpressCAR T Cell Concentrations Stratified by Response. (a) CAR T cell concentrations among ALLO-715 DL3 patients that received any fludarabine/cyclophosphamide/ALLO-647 (FCA) l

Updated on: February 03,2024

Using donor CAR T cells shows promise in treating myeloma patients in phase I trial

by Bob Yirka , Medical XpressCAR T Cell Concentrations Stratified by Response. (a) CAR T cell concentrations among ALLO-715 DL3 patients that received any fludarabine/cyclophosphamide/ALLO-647 (FCA) l

Updated on:February 03,2024

Researchers suggest rethinking 'cancer' label for early-stage prostate changes

byOxford University PressCredit: CC0 Public DomainA new paper in theJournal of the National Cancer Instituteindicates that patients may benefit if doctors stop calling certain early-

Updated on: November 10,2024

Researchers suggest rethinking 'cancer' label for early-stage prostate changes

byOxford University PressCredit: CC0 Public DomainA new paper in theJournal of the National Cancer Instituteindicates that patients may benefit if doctors stop calling certain early-

Updated on:November 10,2024

New tools to manage rare eye cancer

by University College DublinTumor secretion of IL-6, IL-13, VEGF-A, and PlGF correlate with clinical characteristics in ex vivo, control-treated, primary UM patient tumors. (A) Schematic of the e

Updated on: January 29,2024

New tools to manage rare eye cancer

by University College DublinTumor secretion of IL-6, IL-13, VEGF-A, and PlGF correlate with clinical characteristics in ex vivo, control-treated, primary UM patient tumors. (A) Schematic of the e

Updated on:January 29,2024

Bone cells suppress cancer metastases

by Thomas Jefferson UniversityCredit: CC0 Public DomainIn breast cancer, there are cases of women and men whose cancer returns in their bones 20-30 years after they were treated for their primary

Updated on: March 30,2024

Bone cells suppress cancer metastases

by Thomas Jefferson UniversityCredit: CC0 Public DomainIn breast cancer, there are cases of women and men whose cancer returns in their bones 20-30 years after they were treated for their primary

Updated on:March 30,2024

Doctors try CRISPR gene editing for cancer, a 1st in the US

by Marilynn MarchioneIn this January 2019 image made from video provided by Penn Medicine, IV bags of CRISPR-edited T cells are prepared for administering to a patient at the Abramson Cancer Center in

Updated on: May 17,2024

Doctors try CRISPR gene editing for cancer, a 1st in the US

by Marilynn MarchioneIn this January 2019 image made from video provided by Penn Medicine, IV bags of CRISPR-edited T cells are prepared for administering to a patient at the Abramson Cancer Center in

Updated on:May 17,2024

Researchers to investigate screening for prostate cancer using MRI—potentially replacing the PSA test

by Medical Research CouncilCredit: Medical Research CouncilA new clinical study will test for the first time if MRI scans can be used for population screening to detect prostate cancer more accur

Updated on: March 06,2024

Researchers to investigate screening for prostate cancer using MRI—potentially replacing the PSA test

by Medical Research CouncilCredit: Medical Research CouncilA new clinical study will test for the first time if MRI scans can be used for population screening to detect prostate cancer more accur

Updated on:March 06,2024